These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3440821)

  • 1. Guanethidine blocks neuropeptide-Y-like inhibitory action of sympathetic nerves on cardiac vagus.
    Potter EK
    J Auton Nerv Syst; 1987 Nov; 21(1):87-90. PubMed ID: 3440821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y.
    Warner MR; Levy MN
    Circ Res; 1989 Dec; 65(6):1536-46. PubMed ID: 2582589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y.
    Potter E
    Neurosci Lett; 1987 Dec; 83(1-2):101-6. PubMed ID: 3441289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged inhibition of cardiac vagal action following sympathetic stimulation and galanin in anaesthetized cats.
    Revington M; Potter EK; McCloskey DI
    J Physiol; 1990 Dec; 431():495-503. PubMed ID: 1712845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of long-lasting effects of sympathetic stimulation after repeated stimulation.
    Hall GT; Gardner TD; Potter EK
    Circ Res; 1990 Jul; 67(1):193-8. PubMed ID: 2364490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of pre- and postjunctional responses to neuropeptide Y and sympathetic stimulation by D-myo-inositol-1,2,6-trisphosphate in the anaesthetised dog.
    Potter EK; Edvinsson L; Gustafsson T
    Eur J Pharmacol; 1992 Oct; 221(2-3):307-14. PubMed ID: 1426007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide YY reduces effects of sympathetic nerves and neuropeptide Y on cardiac vagal action.
    Potter EK; McCloskey DI
    Peptides; 1991; 12(4):805-8. PubMed ID: 1788144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the inhibitory roles of neuropeptide Y and galanin on cardiac vagal action in the dog.
    Moriarty M; Gibbins IL; Potter EK; McCloskey DI
    Neurosci Lett; 1992 May; 139(2):275-9. PubMed ID: 1376882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desensitization by neuropeptide Y of effects of sympathetic stimulation on cardiac vagal action in anaesthetised dogs.
    Moriarty M; Potter EK; McCloskey DI
    J Auton Nerv Syst; 1993 Oct; 45(1):21-8. PubMed ID: 8227962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological separation of cardio-accelerator and vagal inhibitory capacities of sympathetic nerves.
    Moriarty M; Potter EK; McCloskey DI
    J Auton Nerv Syst; 1993 Apr; 43(1):7-16. PubMed ID: 8315212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac vagal action and plasma levels of neuropeptide Y following intravenous injection in the dog.
    Potter EK
    Neurosci Lett; 1987 Jun; 77(2):243-7. PubMed ID: 3601235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y as a putative modulator of the vagal effects on heart rate.
    Warner MR; Levy MN
    Circ Res; 1989 May; 64(5):882-9. PubMed ID: 2706760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic-parasympathetic interactions at the heart, possibly involving neuropeptide Y, in anaesthetized dogs.
    Revington ML; McCloskey DI
    J Physiol; 1990 Sep; 428():359-70. PubMed ID: 2231416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of vagal action following sympathetic stimulation is modulated by prejunctional alpha 2-adrenoceptors in the dog.
    Hall GT; Potter EK
    J Auton Nerv Syst; 1990 Jun; 30(2):129-37. PubMed ID: 2164545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic-parasympathetic interactions at the heart in the anaesthetised rat.
    Smith-White MA; Wallace D; Potter EK
    J Auton Nerv Syst; 1999 Feb; 75(2-3):171-5. PubMed ID: 10189119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of vagal vasodilatation by a selective neuropeptide Y Y2 receptor agonist in the bronchial circulation of anaesthetised dogs.
    Mahns DA; Lacroix JS; Potter EK
    J Auton Nerv Syst; 1998 Nov; 73(2-3):80-5. PubMed ID: 9862381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromodulation of the cardiac vagus: comparison of neuropeptide Y and related peptides.
    Kilborn MJ; Potter EK; McCloskey DI
    Regul Pept; 1985 Oct; 12(2):155-61. PubMed ID: 2866566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cardiac vagal action by galanin but not neuropeptide Y in the brush-tailed possum Trichosurus vulpecula.
    Courtice GP; Potter EK; McCloskey DI
    J Physiol; 1993 Feb; 461():379-86. PubMed ID: 7688807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vagal action on atrioventricular conduction and its inhibition by sympathetic stimulation and neuropeptide Y in anaesthetised dogs.
    Pirola FT; Potter EK
    J Auton Nerv Syst; 1990 Sep; 31(1):1-12. PubMed ID: 2262662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
    Awad SJ; Einstein R; Potter EK; Richardson DP
    Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.